DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Anticalin
Anticalin
Strategies and Challenges for the Next Generation of Therapeutic Antibodies
EURL ECVAM Recommendation on Non-Animal-Derived Antibodies
Generation of Novel Intracellular Binding Reagents Based on the Human Γb-Crystallin Scaffold
Anticalins Versus Antibodies: Made-To-Order Binding Proteins for Small Molecules Gregory a Weiss * and Henry B Lowman
WO 2017/013231 Al 26 January 2017 (26.01.2017) P O P C T
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy
Anticalins: a Novel Class of Therapeutic Binding Proteins
Chemical Engineering of Small Affinity Proteins
University of Copenhagen, DK-2200 København N, Denmark * Correspondence:
[email protected]
; Tel.: +45-2988-1134 † These Authors Contributed Equally to This Work
Protein and Antibody Engineering Summit N Engineering Antibodies N Engineering Bispecifics 2020 PLENARY KEYNOTES Oncology Mabs Vs
THE ESSENTIAL PROTEIN ENGINEERING SUMMIT May 1-5
WO 2017/147538 Al 31 August 2017 (31.08.2017) P O P C T
Expanding the Boundaries of Biotherapeutics with Bispecific
Thesis + Long Intro
Type of the Paper (Article, Review, Communication
Affimer - Potential Best-In-Class Antibody Mimetic Pharma & Biotech
Camelid Single-Domain Antibody Directed Against Amyloid Bêta and Methods for Producing Conjugates Thereof
An Albumin-Binding Domain As a Scaffold for Bispecific Affinity Proteins
Top View
A Protein Scaffold, Engineered SPINK2, for Generation of Inhibitors With
In Vitro-Engineered Non-Antibody Protein Therapeutics
Characterisation of Next Generation Affinity Reagents
Protein Binder (Probi) As a New Class of Structurally Robust Non-Antibody Protein Scaffold for Directed Evolution
Novel Functional Strategy for Development of Highly Specific Antibody Drug Conjugates for Non-Hodgkin's Lymphoma
Bispecific Antibodies in Cancer Immunotherapy
Small-Cap Research 312-265-9471
[email protected]
Tumor-Localized Costimulatory T Cell Engagement by the 4-1BB/HER2 Bispecific Antibody-Anticalin Fusion PRS-343 Authors: Marlon J
Advancing E400 Protein Therapeutics Optimising Therapeutic Potential During Research and Development
The Emerging Role of New Protein Scaffold-Based Agents for Treatment of Cancer ULRICH H
Affitin-Dendrimer Conjugates for Multivalency-Enhanced Targeting »
Protein & Antibody Engineering Summit
Alternative Reagents to Antibodies in Imaging Applications
Toxin Neutralization Using Alternative Binding Proteins
PEGS Europe 2011
Anticalin® Proteins As Therapeutic Agents in Human Diseases
Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
Caprion Pharmaceuticals Pieris Proteolab